Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
Cite this paper
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2007). Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC monographs on the evaluation of carcinogenic risks to humans, 91, 1-528.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC Monogr Eval Carcinog Risks Hum. 2007;91:1-528.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. "Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy." IARC monographs on the evaluation of carcinogenic risks to humans, vol. 91, 2007, pp. 1-528.
For EndNote, Zotero or Mendeley:
Open access
Free to read
No reuse license
Open Access
Free full text on PubMed Central (PMC4781221)